Literature DB >> 23208717

Phase diagrams map the properties of antiviral agents directed against hepatitis B virus core assembly.

Lichun Li1, Srinivas Reddy Chirapu, M G Finn, Adam Zlotnick.   

Abstract

Assembly effectors are small molecules that induce inappropriate virus capsid assembly to antiviral effect. To identify attributes of hepatitis B virus (HBV) assembly effectors, assembly reaction products (normal capsid, noncapsid polymer, intermediates, and free dimeric core protein) were quantified in the presence of three experimental effectors: HAP12, HAP13, and AT-130. Effectors bound stoichiometrically to capsid protein polymers, but not free protein. Thermodynamic and kinetic effects, not aberrant assembly, correlate with maximal antiviral activity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23208717      PMCID: PMC3591873          DOI: 10.1128/AAC.01766-12

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  29 in total

Review 1.  How does your virus grow? Understanding and interfering with virus assembly.

Authors:  Adam Zlotnick; Stephen J Stray
Journal:  Trends Biotechnol       Date:  2003-12       Impact factor: 19.536

Review 2.  Hepatitis B virus biology.

Authors:  C Seeger; W S Mason
Journal:  Microbiol Mol Biol Rev       Date:  2000-03       Impact factor: 11.056

3.  Hepatitis B virus and Homo sapiens proteome-wide analysis: A profusion of viral peptide overlaps in neuron-specific human proteins.

Authors:  Rosalia Ricco; Darja Kanduc
Journal:  Biologics       Date:  2010-05-25

4.  The thermodynamics of virus capsid assembly.

Authors:  Sarah Katen; Adam Zlotnick
Journal:  Methods Enzymol       Date:  2009       Impact factor: 1.600

Review 5.  Hepatitis B viruses: reverse transcription a different way.

Authors:  Michael Nassal
Journal:  Virus Res       Date:  2008-03-12       Impact factor: 3.303

Review 6.  Hepatitis B virus resistance to nucleos(t)ide analogues.

Authors:  Fabien Zoulim; Stephen Locarnini
Journal:  Gastroenterology       Date:  2009-09-06       Impact factor: 22.682

7.  Hepatitis B virus capsid assembly is enhanced by naturally occurring mutation F97L.

Authors:  Pablo Ceres; Stephen J Stray; Adam Zlotnick
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

8.  Combination HBV therapy is linked to greater HBV DNA suppression in a cohort of lamivudine-experienced HIV/HBV coinfected individuals.

Authors:  Gail V Matthews; Eric Seaberg; Gregory J Dore; Scott Bowden; Sharon R Lewin; Joe Sasadeusz; Pip Marks; Zachary Goodman; Frances H Philp; Yiwei Tang; Stephen Locarnini; Chloe L Thio
Journal:  AIDS       Date:  2009-08-24       Impact factor: 4.177

9.  Antiviral activity of recombinant ankyrin targeted to the capsid domain of HIV-1 Gag polyprotein.

Authors:  Sawitree Nangola; Agathe Urvoas; Marie Valerio-Lepiniec; Wannisa Khamaikawin; Supachai Sakkhachornphop; Saw-See Hong; Pierre Boulanger; Philippe Minard; Chatchai Tayapiwatana
Journal:  Retrovirology       Date:  2012-02-20       Impact factor: 4.602

10.  Direct binding of a hepatitis C virus inhibitor to the viral capsid protein.

Authors:  Smitha Kota; Virginia Takahashi; Feng Ni; John K Snyder; A Donny Strosberg
Journal:  PLoS One       Date:  2012-02-28       Impact factor: 3.240

View more
  17 in total

1.  Competition between Normative and Drug-Induced Virus Self-Assembly Observed with Single-Particle Methods.

Authors:  Panagiotis Kondylis; Christopher J Schlicksup; Nicholas E Brunk; Jinsheng Zhou; Adam Zlotnick; Stephen C Jacobson
Journal:  J Am Chem Soc       Date:  2018-12-31       Impact factor: 15.419

2.  Local Stabilization of Subunit-Subunit Contacts Causes Global Destabilization of Hepatitis B Virus Capsids.

Authors:  Christopher John Schlicksup; Patrick Laughlin; Steven Dunkelbarger; Joseph Che-Yen Wang; Adam Zlotnick
Journal:  ACS Chem Biol       Date:  2020-05-19       Impact factor: 5.100

3.  Structurally similar woodchuck and human hepadnavirus core proteins have distinctly different temperature dependences of assembly.

Authors:  Alexander A Kukreja; Joseph C-Y Wang; Elizabeth Pierson; David Z Keifer; Lisa Selzer; Zhenning Tan; Bogdan Dragnea; Martin F Jarrold; Adam Zlotnick
Journal:  J Virol       Date:  2014-09-24       Impact factor: 5.103

4.  Preclinical characterization of GLS4, an inhibitor of hepatitis B virus core particle assembly.

Authors:  Guoyi Wu; Bo Liu; Yingjun Zhang; Jing Li; Alla Arzumanyan; Marcia M Clayton; Raymond F Schinazi; Zhaohe Wang; Siegfried Goldmann; Qingyun Ren; Faxhou Zhang; Mark A Feitelson
Journal:  Antimicrob Agents Chemother       Date:  2013-08-19       Impact factor: 5.191

Review 5.  Core protein: A pleiotropic keystone in the HBV lifecycle.

Authors:  Adam Zlotnick; Balasubramanian Venkatakrishnan; Zhenning Tan; Eric Lewellyn; William Turner; Samson Francis
Journal:  Antiviral Res       Date:  2015-06-27       Impact factor: 5.970

6.  Evolution of Intermediates during Capsid Assembly of Hepatitis B Virus with Phenylpropenamide-Based Antivirals.

Authors:  Panagiotis Kondylis; Christopher J Schlicksup; Sarah P Katen; Lye Siang Lee; Adam Zlotnick; Stephen C Jacobson
Journal:  ACS Infect Dis       Date:  2019-02-04       Impact factor: 5.084

7.  Assembly Properties of Hepatitis B Virus Core Protein Mutants Correlate with Their Resistance to Assembly-Directed Antivirals.

Authors:  Lu Ruan; Jodi A Hadden; Adam Zlotnick
Journal:  J Virol       Date:  2018-09-26       Impact factor: 5.103

8.  Synergistic Interactions between Hepatitis B Virus RNase H Antagonists and Other Inhibitors.

Authors:  Elena Lomonosova; Adam Zlotnick; John E Tavis
Journal:  Antimicrob Agents Chemother       Date:  2017-02-23       Impact factor: 5.191

9.  A novel pyridazinone derivative inhibits hepatitis B virus replication by inducing genome-free capsid formation.

Authors:  Ya-Juan Wang; Dong Lu; Yi-Bin Xu; Wei-Qiang Xing; Xian-Kun Tong; Gui-Feng Wang; Chun-Lan Feng; Pei-Lan He; Li Yang; Wei Tang; You-Hong Hu; Jian-Ping Zuo
Journal:  Antimicrob Agents Chemother       Date:  2015-09-08       Impact factor: 5.191

10.  Hepatitis B Virus Capsids Have Diverse Structural Responses to Small-Molecule Ligands Bound to the Heteroaryldihydropyrimidine Pocket.

Authors:  Balasubramanian Venkatakrishnan; Sarah P Katen; Samson Francis; Srinivas Chirapu; M G Finn; Adam Zlotnick
Journal:  J Virol       Date:  2016-03-28       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.